loader
Please Wait
Applying Filters...
menu
    • menu

    List of Written Confirmation(s) issued for 8-Benzyl-7-(2-(ethyl(2-hydroxyethyl)amino)ethyl)theophylline monohydrochloride Active Pharmaceutical Ingredient (API)

    Client Email Product
    2024 US Elections: Harris, Trump differ on abortion rights, ACA, public health spends; agree on need to cut drug prices

    Data Compilation
    #PharmaFlow

    Pipeline Prospector Sept 2024: BMS wins landmark FDA approval for schizophrenia med; Sanofi’s Dupixent okayed for COPD

    Stock Recap
    #PipelineProspector

    Menu

    8-Benzyl-7-(2-(ethyl(2-hydroxyethyl)amino)ethyl)theophylline monohydrochloride

    ACTIVE PHARMA INGREDIENTS

    PRICE INFORMATION

    INTERMEDIATES

    FINISHED DOSAGE FORMULATIONS

    GLOBAL SALES INFORMATION

    MARKET PLACE

    PharmaCompass
    $ API Ref.Price (USD/KG) : 59Xls download

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow
    ListList of Suppliers
    refreshReset Filter
    refresh Reset Filter
    Price Info Price Info
    product-page Product Main Page

    Data in the table can be downloaded after upgrading. In the meantime, you can access the data through the menu.

    Last Updated on PharmaCompass Virtual Booth Country Name of the Firm Written Confirmation No. Product Name Issue Date Valid Till Address of the Firm
    07/09/2021 Bakul Group
    India
    		 M/s Bakul Pharma Pvt Ltd WC-0375 Bamifylline HCl IH 2023-02-02 2025-09-13 Plot No. - 6202, G.I.D.C, Estate, At & Post,- Ankleshwar, Dist.-Bharuch- 393 002, Gujarat, India
    01/01/2018 Zydus Lifesciences
    India
    		 M/s. Zydus Nycomed Healthcare Pvt. Ltd., WC-0204 Bamifylline Hydrochloride (IH) 2019-07-08 2022-07-08 C-4, MIDC, Village- Pawane, Thane- Belapur Road, Vashi, Navi Mumbai- 400 706